RYR2 sequencing reveals novel missense mutations in a Kazakh idiopathic ventricular tachycardia study cohort

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Ion Channel Biology

Background:

• Channelopathies, arising from ion channel dysfunction (e.g., potassium, calcium), are significant causes of heart failure and sudden cardiac death.
• The human ryanodine receptor 2 (RYR2) is crucial for calcium regulation in cardiac myocytes and is frequently mutated in catecholaminergic polymorphic ventricular tachycardia (CPVT1).

Observation:

• A study investigated 35 Kazakhstani patients with ventricular arrhythmias, including those with CPVT and idiopathic ventricular tachycardia (VT).
• RYR2 gene hot-spot regions were analyzed for variants.
• Two novel RYR2 variants were discovered: a de novo mutation (p.D4631V) in a CPVT patient and a rare variant (p.V1810L) of uncertain significance in an idiopathic VT patient.

Findings:

• A de novo RYR2 mutation (c.13892A>T; p.D4631V) was identified in a patient with catecholaminergic polymorphic ventricular tachycardia.
• A novel rare RYR2 variant (c.5428G>C; p.V1810L) was found in a patient with idiopathic VT, potentially representing a low-penetrance or susceptibility variant.
• A known variant associated with arrhythmogenic right ventricular dysplasia type 2 (ARVD2) was also identified.

Implications:

• These findings contribute to understanding the genetic basis of cardiac channelopathies and ventricular arrhythmias.
• The identification of novel RYR2 variants expands the known mutation landscape for CPVT and idiopathic VT.
• Integrating prediction scores and databases is vital for assessing the pathogenicity of rare variants in underrepresented populations.